Consistent with the results of our RNA-seq data, the expression levels of FOS (1.554 ± 0.4429, p = 0.0035) and RGS19 (1.497 ± 0.5682, p = 0.0196) were significantly higher in vitiligo lesions than in normal samples, while the expression levels of BNIP3 (−0.1705 ± 0.1336, p = 0.2226), TNFSF10 (0.3146 ± 0.1865, p = 0.1137), PEX3 (0.3394 ± 0.2225, p = 0.1495), DAPK1 (6.013 ± 2.973, p = 0.0627), SERPINA1 (7.702 ± 7.544, p = 0.3246), CX3CL1 (5.194 ± 3.359, p = 0.1443), and DLC1 (3.315 ± 3.131, p = 0.3077) showed no significant difference between two groups (Figure 7). The gene discussed is RGS19; the disease is vitiligo.